BIOMETRY

Predictive asthma management through biomarker data and personalized insights. This innovative healthcare company empowers patients to proactively manage their asthma. They leverage patented sensor technology to measure airway inflammation via breath analysis, determining attack risk, medication adherence, and environmental trigger impact. Their app integrates clinical and environmental factors to identify symptom root causes, while their prediction engine builds personalized risk models. Action Founded in 2013, headquartered in Boston, United States. The company has raised $8.6M at the Seed stage backed by investors including Dexcom Ventures, CareSource, Elevate Ventures, TiE ScaleUp, MassChallenge. Operating in HealthTech > Disease Self Management, High Tech > IoT Applications.